|
1. Pourhajibagher M, Hashemi FB, Pourakbari B, Aziemzadeh M, Bahador A. Antimicrobial resistance of Acinetobacter baumannii to imipenem in Iran: a systematic review and meta-analysis. Open Microbiol J 2016; 10: 32-42. 2. Howard A, O'Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence 2012; 3(3): 243-50. 3. Kroger C, Kary SC, Schauer K, Cameron AD. Genetic regulation of virulence and antibiotic resistance in Acinetobacter baumannii. Genes (Basel) 2016; 8(1): pii: E12. 4. Ni Z, Chen Y, Ong E, He Y. Antibiotic resistance determinant-focused Acinetobacter baumannii vaccine designed using reverse vaccinology. Int J Mol Sci 2017; 18(2): pii: E458. 5. Ahmad TA, Tawfik DM, Sheweita SA, Haroun M, El-Sayed LH. Development of immunization trials against Acinetobacter baumannii. Trials Vaccinol 2016; 5: 53-60. 6. Hua X, Liu L, Fang Y, Shi Q, Li X, Chen Q, et al. Colistin resistance in Acinetobacter baumannii MDR-ZJ06 revealed by a multiomics approach. Front Cell Infect Microbiol 2017; 7: 45. 7. Singh R, Capalash N, Sharma P. Reverse vaccinology: developing vaccine against MDR Acinetobacter baumannii. J Vaccines Vaccin 2016; 7(3): 1-3. 8. Eslami E, Doosti A. Cloning and expression study of the hcpD gene of Helicobacter pylori. J Ardabil Uni Med Sci 2017; 17(1): 499-510. [in Persian] 9. Moriel DG, Beatson SA, Wurpel DJ, Lipman J, Nimmo GR, Paterson DL, et al. Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii. PLoS One 2013; 8(10): e77631. 10. Tidhar A, Flashner Y, Cohen S, Levi Y, Zauberman A, Gur D, et al. The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague. PLoS One 2009; 4(9): e7023. 11. Doosti A, Ghasemi-Dehkordi P, Kargar M, Sharifi A. Generation of divalent DNA vaccine based on p39 and shiga-like toxin 2 (stx2) genes. Genetika 2015; 47(2): 499-507. 12. Ghorbani M, Doosti A. Isolation and cloning of Helicobacter Pylori ureE gene into pIRES2-DSRed expression vector to generate a gene vaccine. J Birjand Uni Med Sci 2016; 23(4): 286-97. [in Persian] 13. Snitkin ES, Zelazny AM, Montero CI, Stock F, Mijares L, Murray PR, et al. Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proc Natl Acad Sci USA 2011; 108(33): 13758-63. 14. Taiwo AA, Falilat AJ, Ezemuel YS. Computational design of peptide vaccine against Acinetobacter baumannii infection using comparative genomic approach. Comput Biol Bioinform 2014; 2(1): 13-18. 15. Jorritsma SH, Gowans EJ, Grubor-Bauk B, Wijesundara DK. Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines. Vaccine 2016; 34(46): 5488-94. 16. Luo G, Lin L, Ibrahim AS, Baquir B, Pantapalangkoor P, Bonomo RA, et al. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PLoS One 2012; 7(1): e29446. 17. Lin L, Tan B, Pantapalangkoor P, Ho T, Hujer AM, Taracila MA, et al. Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes. Vaccine 2013; 31(2): 313-8. 18. Singh R, Garg N, Shukla G, Capalash N, Sharma P. Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted In silico as a potential vaccine candidate. Front Microbiol 2016; 7: 158. 19. Huang W, Wang S, Yao Y, Xia Y, Yang X, Long Q, et al. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections. Vaccine 2015; 33(36): 4479-85.
|
.png){kind=logo}
